Source:http://linkedlifedata.com/resource/pubmed/id/10080557
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-3-23
|
pubmed:abstractText |
Dose reduction strategies for the maintenance treatment of schizophrenia are designed to maintain the benefits of antipsychotic drug therapy while reducing risks. Previous strategies with decanoate preparations have been based on the use of lower doses per injection to achieve dose reduction; these strategies have achieved dose reduction but have resulted in some increase in symptoms. The authors tested a new dose reduction approach: increasing the interval between injections during intramuscular decanoate antipsychotic treatment.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0002-953X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
156
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
412-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10080557-Adult,
pubmed-meshheading:10080557-Delayed-Action Preparations,
pubmed-meshheading:10080557-Double-Blind Method,
pubmed-meshheading:10080557-Drug Administration Schedule,
pubmed-meshheading:10080557-Female,
pubmed-meshheading:10080557-Fluphenazine,
pubmed-meshheading:10080557-Humans,
pubmed-meshheading:10080557-Injections, Intramuscular,
pubmed-meshheading:10080557-Male,
pubmed-meshheading:10080557-Patient Compliance,
pubmed-meshheading:10080557-Patient Satisfaction,
pubmed-meshheading:10080557-Psychotic Disorders,
pubmed-meshheading:10080557-Recurrence,
pubmed-meshheading:10080557-Schizophrenia,
pubmed-meshheading:10080557-Schizophrenic Psychology,
pubmed-meshheading:10080557-Treatment Outcome
|
pubmed:year |
1999
|
pubmed:articleTitle |
Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.
|
pubmed:affiliation |
Maryland Psychiatric Research Center and the Department of Psychiatry, University of Maryland School of Medicine, Baltimore 21228, USA. wcarpent@mprc.umaryland.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|